PATENT CLAIM ANALYSIS

Application Number: 15898018
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "486000"]

Abstract:
Abuse-resistant, controlled release opioid tablets are a combination containing an opioid antagonist such as naloxone at a level above that needed to suppress the euphoric effect of the opioid, if the combination were crushed to break the controlled release properties causing the opioid and opioid antagonist to be released as a immediate release product as a single dose. The controlled release nature of the table prevents the accumulation of orally effective amounts of opioid antagonist when taken normally. The opioid antagonist is contained in a controlled-release matrix and released, over time, with the opioid.

Claim (Index 3):
The method according to  claim 1 , wherein the opioid agonist is a pharmaceutically acceptable morphine and said opioid antagonist is naltrexone.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.71186
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15159465', '14859195', '14859200', '14725369', '14136443']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.776744837829987
- 35 USC 102 Novelty (BERT): 0.5557807689627933
- Combined Prediction Score: 0.7546484309432677
- Mean Citation Score: 434.590492
- Max Citation Score: 438.48575
- Similarity Product: 338.1076518752277

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test